Dyslipaemia, atherosclerosis risk and increased hsCRP and inflammatory and oxidative status in the Spanish population. Database analysis of previous studies performed in Spain - DARIOS

Study identifier:NIS-CES-DUM-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Dyslipaemia, atherosclerosis risk and increased hsCRP and inflammatory and oxidative status in the Spanish population

Medical condition

Dyslipaemia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

30181

Study type

Observational

Age

35 Years - 74 Years

Date

Study Start Date: 01 Nov 2009
Primary Completion Date: 01 Oct 2011
Study Completion Date: 01 Oct 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria